Geneservice Ltd announces an agreement to distribute selected genomic resources developed by the Wellcome Trust Sanger Institute

Geneservice Ltd (Cambridge, UK) the leading contract research organisation and biological resource supplier today announced the completion of a worldwide agreement to distribute selected genomic resources developed by world renowned Wellcome Trust Sanger Institute.

This agreement further strengthens Geneservice’s position as the leading genomic resource supplier. These Sanger Institute genomic resources are a significant addition to the reagent portfolio, and will initially add three important libraries to the existing portfolio of over 12 million clones.

These genomic resources are available to order on-line now, via the Geneservice website at the article webpage. All orders will be backed by the usual exceptional level of customer service and technical support that customers have come to expect from Geneservice Ltd.

Commenting on the importance of the agreement, Tom Weaver, CEO stated, “Geneservice is extremely pleased to be working with The Wellcome Trust Sanger Institute to market these unique resources. Geneservice originated from the UK Medical Research Council when it was part of Human Genome Program on the Hinxton Genome Campus, where the Sanger Institute is located. It is our aim to provide a worldwide portal for scientists to access the most advanced research programs in the field of genomics. This agreement further re-enforces our commitment to enabling rapid and open access to the highest quality biological tools for life science research.”